Catalyst Wire Dossier Catalyst Wire Dossier

Opebacan

· XOMA (US) LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Opebacan, covering 2012-07-30 to 2012-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of Opebacan in Patients Undergoing Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) [Phase 1, Phase 2]

See pricing